Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES).

Bruyere O, Kanis JA, Ibar-Abadie ME, Alsayed N, Brandi ML, Burlet N, Cahall DL, Chines A, Devogelaer JP, Dere W, Goel N, Hughes N, Kaufman JM, Korte S, Mitlak BH, Niese D, Rizzoli R, Rovati LC, Reginster JY.

Osteoporos Int. 2010 May;21(5):713-22. doi: 10.1007/s00198-010-1190-9. Epub 2010 Mar 18.

PMID:
20238101
2.

Guidelines for interactions between clinical faculty and the pharmaceutical industry: one medical school's approach.

Coleman DL, Kazdin AE, Miller LA, Morrow JS, Udelsman R.

Acad Med. 2006 Feb;81(2):154-60.

PMID:
16436576
3.
4.

Transparency and trust.

Compston JE.

Osteoporos Int. 2010 May;21(5):711-2. doi: 10.1007/s00198-010-1191-8. Epub 2010 Mar 18. No abstract available.

PMID:
20238100
5.

The impact of conflict of interest on trust in science.

Friedman PJ.

Sci Eng Ethics. 2002 Jul;8(3):413-20.

PMID:
12353371
6.

Ghostwriting in medical literature.

[No authors listed]

Int J Occup Environ Health. 2011 Apr-Jun;17(2):168-77. No abstract available.

PMID:
21618949
7.

Conflicts of interest, authorship, and disclosures in industry-related scientific publications: the tort bar and editorial oversight of medical journals.

Hirsch LJ.

Mayo Clin Proc. 2009 Sep;84(9):811-21. doi: 10.1016/S0025-6196(11)60491-6. No abstract available. Erratum in: Mayo Clin Proc. 2010 Jan;85(1):102.

8.

Managing conflicts of interest: who, and how?

Katelaris A.

Med J Aust. 2012 Apr 16;196(7):427. No abstract available.

PMID:
22509861
9.

The relationship between paediatricians and commerce.

Hilliard T, Chambers T.

Paediatr Respir Rev. 2006 Mar;7(1):54-9. Epub 2005 Dec 6. Review.

PMID:
16473818
10.
11.

Conflicts of interest: a review of institutional policy in Australian medical schools.

Mason PR, Tattersall MH.

Med J Aust. 2011 Feb 7;194(3):121-5. Erratum in: Med J Aust. 2011 Feb 21;194(4):216.

PMID:
21299485
12.

Ghosts still present in the medical machine.

Jones N.

Nature. 2009 Sep 17;461(7262):325. doi: 10.1038/461325a. No abstract available.

PMID:
19759590
13.

Conflicts of interest: a review of institutional policy in Australian medical schools. Comment.

Milligan E, Cripps AW.

Med J Aust. 2011 Aug 1;195(3):156; author reply 156. No abstract available.

PMID:
21806538
14.

Uneasy alliance--clinical investigators and the pharmaceutical industry.

Bodenheimer T.

N Engl J Med. 2000 May 18;342(20):1539-44. No abstract available.

PMID:
10816196
15.

The corporate coauthor.

Fugh-Berman A.

J Gen Intern Med. 2005 Jun;20(6):546-8.

16.

[Psychiatrists and the pharmaceutical industry].

Helmchen H.

Nervenarzt. 2003 Nov;74(11):955-64. German.

PMID:
14694885
17.

Conflict of interest in university-industry research relationships: realities, politics, and values.

Kodish E, Murray T, Whitehouse P.

Acad Med. 1996 Dec;71(12):1287-90. No abstract available.

PMID:
9114885
18.

Pharmacists and industry: guidelines for ethical interactions.

American College of Clinical Pharmacy, Hatton RC, Chavez ML, Jackson E, Maurey J, Barriere SL, Couchenour R, Evens RP, Gunning K, Hume AL, Hutchison LC, Matzke GR, Noviasky JA, Rospond RM, Kelloway JS, Stevenson JG, Vanderveen RP, Verme-Gibboney CN, Walters D.

Pharmacotherapy. 2008 Mar;28(3):410-20. doi: 10.1592/phco.28.3.410. No abstract available.

PMID:
18294122
19.

Conflicts of interest and disclosure in the American Psychiatric Association's Clinical Practice Guidelines.

Cosgrove L, Bursztajn HJ, Krimsky S, Anaya M, Walker J.

Psychother Psychosom. 2009;78(4):228-32. doi: 10.1159/000214444. Epub 2009 Apr 28.

PMID:
19401623
20.

'Interests' in medicine and the inadequacy of disclosure.

Kerridge I.

Aust N Z J Psychiatry. 2012 Jun;46(6):501-3. doi: 10.1177/0004867412446493. No abstract available.

PMID:
22679203

Supplemental Content

Support Center